BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24518295)

  • 1. Synthesis, selective cytotoxicities and probable mechanism of action of 7-methoxy-3-arylflavone-8-acetic acids.
    Zhou ZZ; Gu CP; Deng YH; Yan GH; Li XF; Yu L; Chen WH; Liu SW
    Bioorg Med Chem; 2014 Mar; 22(5):1539-47. PubMed ID: 24518295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticancer activities of 3-arylflavone-8-acetic acid derivatives.
    Yan GH; Li XF; Ge BC; Shi XD; Chen YF; Yang XM; Xu JP; Liu SW; Zhao PL; Zhou ZZ; Zhou CQ; Chen WH
    Eur J Med Chem; 2015 Jan; 90():251-7. PubMed ID: 25461325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mono- or di-fluorinated analogues of flavone-8-acetic acid: synthesis and in vitro biological activity.
    Carrara M; Zampiron A; Barbera M; Caputo A; Bisi A; Gobbi S; Belluti F; Piazzi L; Rampa A; Valenti P
    Anticancer Res; 2005; 25(2A):1179-85. PubMed ID: 15868960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
    Barbera M; Caputo A; Zampiron A; Gobbi S; Rampa A; Bisi A; Carrara M
    Oncol Rep; 2008 Jan; 19(1):187-96. PubMed ID: 18097594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid.
    Gobbi S; Rampa A; Bisi A; Belluti F; Valenti P; Caputo A; Zampiron A; Carrara M
    J Med Chem; 2002 Oct; 45(22):4931-9. PubMed ID: 12383019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 3-alkoxy analogues of flavone-8-acetic acid.
    Gobbi S; Rampa A; Bisi A; Belluti F; Piazzi L; Valenti P; Caputo A; Zampiron A; Carrara M
    J Med Chem; 2003 Aug; 46(17):3662-9. PubMed ID: 12904070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid.
    Cao Z; Joseph WR; Browne WL; Mountjoy KG; Palmer BD; Baguley BC; Ching LM
    Br J Cancer; 1999 May; 80(5-6):716-23. PubMed ID: 10360649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.
    Joseph WR; Cao Z; Mountjoy KG; Marshall ES; Baguley BC; Ching LM
    Cancer Res; 1999 Feb; 59(3):633-8. PubMed ID: 9973211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor agents. Part 226: synthesis and cytotoxicity of 2-phenyl-4-quinolone acetic acids and their esters.
    Xia Y; Yang ZY; Xia P; Bastow KF; Nakanishi Y; Nampoothiri P; Hamel E; Brossi A; Lee KH
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2891-3. PubMed ID: 14611851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-modulating and anti-vascular activities of two xanthenone acetic acid analogues: A comparative study to DMXAA.
    Barbera M; Kettunen MI; Caputo A; Hu DE; Gobbi S; Brindle KM; Carrara M
    Int J Oncol; 2009 Jan; 34(1):273-9. PubMed ID: 19082498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of flavone-2'-carboxylic acid analogues as potential antitumor agents.
    Valenti P; Bisi A; Rampa A; Gobbi S; Belluti F; Da Re P; Cima L; Carrara M
    Anticancer Drug Des; 1998 Dec; 13(8):881-92. PubMed ID: 10335265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure elucidation and in vitro anticancer activities of novel derivatives of diethyl (2E)-2-[(2E)-(1-arylimidazolidin-2-ylidene)hydrazono]succinate and ethyl (4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetate.
    Sztanke M; Rzymowska J; Sztanke K
    Bioorg Med Chem; 2013 Dec; 21(23):7465-80. PubMed ID: 24126095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule cytokine inducers causing tumor necrosis.
    Baguley BC
    Curr Opin Investig Drugs; 2001 Jul; 2(7):967-75. PubMed ID: 11757800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
    Browne WL; Wilson WR; Baguley BC; Ching LM
    Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice.
    Ching LM; Goldsmith D; Joseph WR; Körner H; Sedgwick JD; Baguley BC
    Cancer Res; 1999 Jul; 59(14):3304-7. PubMed ID: 10416582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumour activity of β-hydroxyisovalerylshikonin analogues.
    Rao Z; Liu X; Zhou W; Yi J; Li SS
    Eur J Med Chem; 2011 Sep; 46(9):3934-41. PubMed ID: 21689869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of some analogues of flavone acetic acid.
    Valenti P; Fabbri G; Rampa A; Bisi A; Gobbi S; Da Re P; Carrara M; Sgevano A; Cima L
    Anticancer Drug Des; 1996 Apr; 11(3):243-52. PubMed ID: 8663911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 mitogen-activated protein kinase is required for the antitumor activity of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid.
    Wu Q; Quan H; Xu Y; Li Y; Hu Y; Lou L
    J Pharmacol Exp Ther; 2012 Jun; 341(3):709-17. PubMed ID: 22414857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and activation of NF-kappaB in human tumor cell lines.
    Woon ST; Baguley BC; Palmer BD; Fraser JD; Ching LM
    Oncol Res; 2002; 13(2):95-101. PubMed ID: 12392157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).
    Ching LM; Joseph WR; Crosier KE; Baguley BC
    Cancer Res; 1994 Feb; 54(4):870-2. PubMed ID: 8313372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.